Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
1.010
-0.010 (-0.98%)
At close: Mar 9, 2026, 4:00 PM EDT
0.995
-0.015 (-1.49%)
After-hours: Mar 9, 2026, 6:38 PM EDT
Citius Oncology Cash Flow Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
| Net Income | -23.64 | -24.76 | -21.15 | -12.7 | -10.87 |
| Stock-Based Compensation | 10.47 | 8.32 | 7.5 | 1.97 | - |
| Other Operating Activities | 1.06 | 1.06 | 0.58 | 0.58 | 1.15 |
| Change in Inventory | -6.89 | -12.65 | -2.13 | - | - |
| Change in Accounts Payable | 4.57 | 9.52 | 2.42 | 1.2 | 0.18 |
| Change in Other Net Operating Assets | 5.06 | 13.02 | 12.91 | 8.96 | 9.53 |
| Operating Cash Flow | -12.85 | -5.49 | 0.13 | - | - |
| Sale (Purchase) of Intangibles | -10.15 | -5.75 | -5 | - | - |
| Investing Cash Flow | -10.15 | -5.75 | -5 | - | - |
| Long-Term Debt Issued | - | - | 3.8 | - | - |
| Net Debt Issued (Repaid) | - | - | 3.8 | - | - |
| Issuance of Common Stock | 30.29 | 15.17 | - | - | - |
| Other Financing Activities | - | - | 1.07 | - | - |
| Financing Cash Flow | 30.29 | 15.17 | 4.87 | - | - |
| Net Cash Flow | 7.3 | 3.92 | 0 | - | - |
| Cash Interest Paid | 0.2 | 0.19 | - | - | - |
| Levered Free Cash Flow | -24.72 | -8.13 | -1.94 | 4.55 | - |
| Unlevered Free Cash Flow | -24.56 | -7.99 | -1.94 | 4.55 | - |
| Change in Working Capital | -1.31 | 9.89 | 13.2 | 10.16 | 9.71 |
Source: S&P Capital IQ. Standard template.
Financial Sources.